VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV was delisted on the 7th of August, 2024.
44 hedge funds and large institutions have $51.4M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 1 closing their positions.
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
19% more funds holding
Funds holding: 37 → 44 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less capital invested
Capital invested by funds: $55M → $51.4M (-$3.6M)
31% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$1.38M |
| 2 |
FPC
Falcon Point Capital
San Francisco,
California
|
+$784K |
| 3 |
Millennium Management
New York
|
+$510K |
| 4 |
State Street
Boston,
Massachusetts
|
+$203K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$151K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$254K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$36K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$28.1K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$22.2K |
| 5 |
TA
Teachers Advisors
New York
|
-$21K |
VBIV Hedge Fund Activity: Q3 2017 in Review
44 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q3 2017, worth a combined $51.4M — down 6.5% from $55M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new VBIV positions and 1 closed out — a net gain of 8 holders — while 9 added to existing stakes and 13 trimmed.
The largest buyer was Russell Investments Group, opening a new position worth an estimated $1.38M. The largest seller was Vanguard Group, cutting an estimated $254K.
- 44 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q3 2017, up from 37 in Q2 2017.
- Funds reported $51.4M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q3 2017, down 6.5% quarter-over-quarter.
- 9 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q3 2017 and 1 closed out, a net change of +8 holders.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q3 2017 was Russell Investments Group, an estimated $1.38M added.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q3 2017 was Vanguard Group, an estimated $254K sold.
Based on aggregated 13F filings for Q3 2017.